[Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period]

Jpn J Antibiot. 2000 Jan:53 Suppl A:56-9.
[Article in Japanese]
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adenocarcinoma / drug therapy
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Carcinoma, Large Cell / drug therapy
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Carcinoma, Squamous Cell / drug therapy
  • Erythromycin / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / mortality
  • Male
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Immunologic Factors
  • Erythromycin